Levels of botulinum neurotoxin (BoNT) proteolytic activity were compared using a cell-free assay and living neurons to measure extracellular and intracellular enzymatic activity. Within the cell-free reaction model, BoNT serotypes A and E (BoNT/A and BoNT/E, respectively) were reversibly inhibited by chelating Zn 2؉ with N,N,N,N-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN). BoNT/E required relatively long incubation with TPEN to achieve total inhibition, whereas BoNT/A was inhibited immediately upon mixing. When naïve Zn 2؉ -containing BoNTs were applied to cultured neurons, the cellular action of each BoNT was rapidly inhibited by subsequent addition of TPEN, which is membrane permeable. Excess Zn 2؉ added to the culture medium several hours after poisoning fully restored intracellular toxin activity. Unlike TPEN, EDTA irreversibly inhibited both BoNT/A and -E within the cell-free in vitro reaction. Excess Zn 2؉ did not reactivate the EDTA-treated toxins. However, application of EDTA-treated BoNT/A or -E to cultured neurons demonstrated normal toxin action in terms of both blocking neurotransmission and SNAP-25 proteolysis. Different concentrations of EDTA produced toxin preparations with incrementally reduced in vitro proteolytic activities, which, when applied to living neurons showed undiminished cellular potency. This suggests that EDTA renders the BoNT proteolytic domain conformationally inactive when tested with the cell-free reaction, but this change is corrected during entry into neurons. The effect of EDTA is unrelated to Zn 2؉ because TPEN could be applied to living cells before or after poisoning to produce rapid and reversible inhibition of both BoNTs. Therefore, bound Zn 2؉ is not required for toxin entry into neurons, and removal of Zn 2؉ from cytosolic BoNTs does not irreversibly alter toxin structure or function. We conclude that EDTA directly alters both BoNTs in a manner that is independent of Zn 2؉ .Botulinum neurotoxins (BoNTs) cause muscle paralysis by cleaving key proteins in nerve terminals. Combined incidents of botulism caused by BoNT serotypes A and E (BoNT/A and BoNT/E, respectively) constitute 50 to 60% of all botulism outbreaks in the United States (41, 49). BoNT poisoning frequently entails critical care medical treatment throughout the course of the disease because no cure exists to reverse the consequent paralysis. The duration and severity of symptoms may last for many months. After a botulism case is confirmed, strong emphasis is placed on identifying BoNTs in foods or environmental samples in order to document the source of the poisoning, prevent further spread of the disease, and help understand the molecular basis by which these toxins are transmitted.The light-chain (LC) domain of each BoNT is a Zn-dependent metalloprotease (33). Cellular toxicity from the LC is imparted by two other regions of the BoNT protein that mediate toxin binding to nerve terminals and LC translocation into the neuronal cytoplasm (28). Within the nerve terminal, BoNT/A and -E LCs cut the synapt...